每经AI快讯,有投资者在投资者互动平台提问:吉利德研发的预防艾滋病的药前景非常好,作为国产艾滋病药的先锋,艾迪在这个领域理应有所作为,不知公司是否已经开展预防艾滋病的药物研发?艾迪药业(688488.SH)9月20日在投资者互动平台表示,在抗HIV领域,公司瞄准国际最新研发方向,针对HIV病毒生命周期不同阶段的防治靶点,正布局抗HIV药物系列在研管线,包括新一代抗HIV整合酶抑制剂ACC017、抗...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.